Skip to main content
. 2021 May 14;4(2):35–44. doi: 10.36401/JIPO-20-34

Figure 1.

Figure 1

COVID-19 outcomes among 25 patients receiving ICI within 1 year of COVID-19 diagnosis and 25 case control patients. Flow graphic demonstrating the hospitalization status, highest level of care, and final COVID-19 outcomes among the two patient cohorts (25 patients with prior ICI use and 25 controls). Complications are defined as patients who continue to require supplemental oxygen after discharge. COVID-19: coronavirus disease 2019; ICI: immune checkpoint inhibitor.